Small-Molecule Injectable Market
Market Insights on Small-Molecule Injectable covering sales outlook, demand forecast & up-to-date key trends
Small-Molecule Injectable Market by Product (Small Molecule Antibiotics, Chemotherapy Agents, Local and General Anaesthetics), Application ( Oncology, Pain Management, Cardiovascular Diseases), Route of Administration (Intravenous, Intramuscular, Subcutaneous), End User & Region - Forecast to 2021-2031
Small-Molecule Injectable Market Snapshot
[270 Pages Report] The global Small-molecule Injectable Market was valued at US$ 52.7 Bn in 2020 and is expected to reach US$ 112.9 Bn by 2031, finds Future Market Insights (FMI) in a recent market survey.
Increasing application of analgesics and antibiotics during surgeries for preventing infections and reduce sensitization is spurring the demand for small-molecule injectables. Driven by this, sales of small-molecule injectables are expected to rise at a 7.3% CAGR through 2031.
Small Molecule Injectable Market Outlook:
|
Data Points |
Market Insights |
|
Market Value 2020 |
USD 52.75 Bn |
|
Market Value 2021 |
USD 55.77 Bn |
|
CAGR 2021-2031 |
7.3% |
|
Key Players |
The key players in Small molecule injectable market are Aurobindo Pharma Limited, Sun Pharmaceutical Industries Ltd, Novartis AG, and Merck & Co. Inc |
Let us know your requirement to get
100% FREE customization
2016-2020 Small Molecule Injectable Market Demand Outlook Compared to 2021-2031 Forecast
Sales of small molecule injectable grew at a CAGR of 4.8% between 2016 and 2020. Growing prevalence of chronic diseases and fast track approvals of new drugs for treatment are expected to drive sales of small molecule injectables.
Leading pharmaceutical companies are aiming at production facility expansion through mergers acquisitions and collaborations to improve their product portfolios. For Instance, In April 2021, Dr. Reddy's Laboratories announced the launch of a generic version of Sapropterin Dihydrochloride powder for oral solution, 100 mg in the U.S. Market.
In July, 2020, USFDA cGMP inspection completed at Cipla's API manufacturing facility in Virgonagar, Bengaluru. These developments are expected to bode well for the global small-molecule injectables market.
Considering this, FMI expects the global small molecule injectable to grow at a CAGR of 7.3% through 2031.
Which Factors Are Restraining Demand for Small Molecule Injectable?
Small-molecule injectables require complex equipment for manufacturing, each of which need proper certification and sterilization before production. This leads to high operating costs and high debt levels too due to purchase and renting of capital equipment.
In addition to this, regulatory cost burden is high due to FDA mandates for maintaining quality of product while manufacturing,packaging, storage and distribution.
Monopoly in manufacturing and sourcing of small-molecule injectables is also causing disruptions in supply chain. This might hamper the availability of drugs, resulting in dampened sales prospects for small-molecule injectables.
What is the Impact of the COVID-19 Crisis on the Small-Molecule Injectable Market?
The COVID-19 pandemic is anticipated to have a negative impact on the small molecule injectable market due to limited production and transportation-related delays. Lockdown restrictions further made it difficult for freight service providers to deliver raw material.
However, resumption in production activities and across various sectors is expected to augment recovery of the small-molecule injectables market in the forthcoming years. Manufacturers and healthcare professionals are also amplifying their efforts to spread awareness regarding immunotherapy treatment options. This is expected to propel sales of small-molecule injectables over the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
Will the U.S. Remain a Key Small-Molecule Injectable Market?
The U.S. is estimated to account for over 92.4 % of the North America small-molecule injectable market in 2021. Demand for small-molecule injectables is increasing in the U.S due to increasing incidence of chronic diseases among the geriatric population, and growing rates of hospitalisation and surgeries.
Why is Germany Considered a Lucrative Small-Molecule Injectable Market?
Germany is expected to account for 21.9% of the Europe small-molecule injectable market in Europe by 2031. Growing demand for small-molecule injectables in Germany is attributable to rapid expansion of healthcare infrastructure, presence of prominent players and rapid adoption of technologically advanced equipment and processes in the healthcare sector.
What are the Factors Fueling Small-Molecule Injectable Sales in China?
Sales of small-molecule injectables in China are projected to grow at a 9.0% CAGR in East Asia throughout the forecast period. Increasing use of oncology-related medicines in hospitals for treatment of various types of cancer, rising demand for analgesics for surgical pain management and wide avaiblity of biopharmaceutical raw material are expected to continue pushing sales of small-molecule injectables in China.
How will the Small-Molecule Injectable Market Expand Across India?
Demand for small-molecule injectables in India is expected to rise at an impressive 11.1% CAGR over the forecast period. Rising health care awareness, surging demand for advanced medical technologies, increasing number of hospitalization, and streamlined raw material procurement are expected to drive expansion of the small-molecule injectable market in India.
Category-wise Insights
Demand for Analgesics to Continue gaining Traction
By product, the analgesics segment is anticipated to hold the maximum share of 23.9% in 2021, expanding at 8.0% CAGR during the forecast period. Revenues from analgesics are expected to expand further, primarily due to increasing number of accidents, surgeries and hospitalizations. Analgesics help in pain management, relieve anxiety, improve healing and accelerate recovery.
Applications of Small-Molecule Injectables in Infectious Diseases to Remain High
In terms of application, the infectious disease sement in projected to account for 31.7% of the total market share in 2021. Increasing adoption of small-molecules injectable drug in infectious disease control and treatment is expected to continue spurring demand for small-molecule injectables during the forecast period.
Which Route of Administration will be Most Preferred?
By route of administration, the intravenous segment is projected to account for 49.8% of the total market share in 2021. Intravenous route is considered to be the fastest route of drug administration and injectable are directly introduced into the bloodstream. Considering this, sales of small-molecule injectables in the intravenous route of administration segement are expected to remain high over the forecast period.
Sales of Small-Molecule Injectables through Hospital Pharmacies to Remain High
By distribution channel, hospital pharmacies are anticipated to account for 67.8% of the total small-molecule injectable market share in 2021. Increasing hospitalizations, and the availability of skilled professionals to inject drugs is likely to fuel growth of the segment.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Competitive Landscape
Companies operating in the small molecule Injectable are investing in strategic collaborations, mergers and acquisitions to improve their product portfolios. Drug approvals and production facility expansions will remain a part pf growth strategies adopted by market players to gain a competitive edge. For instance:
- In March 2021, U.S. Food and Drug Administration (FDA) has accepted new drug application for gefapixant, an intravenous administered for the treatment of refractory chronic cough (RCC) in adults.
- In 2021, Novartis announced that small drug molecule (branaplam) is in Phase 2 for spinal muscular atrophy.
- In Jan 2020, Sanofi S.A acquired Syntrox for biotechnological product development for cancer and autoimmune disorders.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Million for Volume |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa |
|
Key Segments Covered |
Product, Application, Route of Administration, Distribution Channel and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Key Questions Answered in Report
-
What is the current value of the global small-molecule injectable market?
The global small-molecule injectable market is projected to expand at a 7.3% CAGR over the forecast period.
-
At what rate did the market grow between 2016 and 2020?
The global small-molecule injectable market expanded at a 4.8% CAGR between 2016 and 2020.
-
What are key trends driving sales of small-molecule injectables?
Increasing adoption of automation in drug production, focus on manufacturing quality, product launch, rising government initiatives and growing market consolidation activities by manufacturer are key trends driving sales of small molecule injectable across the globe.
-
What are the key market statistics of South Korea and Japan?
The South Korea small molecule injectable market is projected to expand at a 5.0% CAGR during the forecast period. Sales of small-molecule injectables in Japan are slated to grow at a 8.8% CAGR during the forecast period.
-
What are the top 5 countries driving demand for small molecule injectable market?
The U.S., China, India, Germany, and Japan are top 5 countries that are driving demand for small molecule injectable market
-
Which are leading companies of small molecule injectable market?
Leading companies of small molecule injectable are Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A S.A., Sun Pharmaceutical Industries Ltd., AstraZeneca Plc, Merck & Co., Inc., Mylan N.V, Cipla Inc., and Dr. Reddy’s Laboratories Ltd.
Small Molecule Injectable Market by Category
By Product:
- Small Molecule Antibiotics
- Chemotherapy Agents
- Local and General Anaesthetics
- Skeletal Muscle Relaxants
- Analgesics
- Anticoagulants
- Anticonvulsants
- Antivirals
- Anti-histamines/ Anti-allergy
- Others
By Application:
- Oncology
- Pain Management
- Cardiovascular Diseases
- Infectious Diseases
- CNS Diseases
- Blood Disorders
- Musculoskeletal Disorders
- Others
By Route of Administration:
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Mail Order Pharmacies
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global small-molecule injectable market is projected to expand at a 7.3% CAGR over the forecast period.
The global small-molecule injectable market expanded at a 4.8% CAGR between 2016 and 2020.
Increasing adoption of automation in drug production, focus on manufacturing quality, product launch, rising government initiatives and growing market consolidation activities by manufacturer are key trends driving sales of small molecule injectable across the globe.
The South Korea small molecule injectable market is projected to expand at a 5.0% CAGR during the forecast period. Sales of small-molecule injectables in Japan are slated to grow at a 8.8% CAGR during the forecast period.
The U.S., China, India, Germany, and Japan are top 5 countries that are driving demand for small molecule injectable market
Leading companies of small molecule injectable are Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A S.A., Sun Pharmaceutical Industries Ltd., AstraZeneca Plc, Merck & Co., Inc., Mylan N.V, Cipla Inc., and Dr. Reddy’s Laboratories Ltd.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation /Development Trends
4. Key Success Factors
4.1. Adoption Analysis, by Region
4.2. Key Disease Epidemiology, By Region
4.3. Pipeline Assessment
4.4. Regulatory Scenario
4.5. Supply Chain
4.6. Key promotional Strategies by Manufacturers
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Growth of Healthcare Sector in Emerging Nations
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increasing Adoption of Small MoleculeSmall-Molecule Injectable
5.2.2. Increasing Demand of Small MoleculeSmall-Molecule Injectable Fromfrom Pain management and Oncology
5.2.3. Frequent Drug Shortages
5.2.4. Geographical expansion
5.2.5. Change in regulatory Scenario
5.2.6. Increasing Affordability of Small MoleculeSmall-Molecule Injectable
5.2.7. R&D in Small MoleculeSmall-Molecule Injectable
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID19 and Impact Analysis
6.5. 2020 Market Scenario
7. Global Small MoleculeSmall-Molecule Injectable Market Demand (in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Small MoleculeSmall-Molecule Injectable Market Analysis 2016-2020 and Forecast 2021-2031, by Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Trend Analysis By Product, 2016–2020
8.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Product, 2021-2031
8.3.1. Small MoleculeSmall-Molecule Antibiotics
8.3.2. Chemotherapy Agents
8.3.3. Local and General AnaestheticsAnesthetics
8.3.4. Skeletal Muscle Relaxants
8.3.5. Analgesics
8.3.6. Anticoagulants
8.3.7. Anticonvulsants
8.3.8. Antivirals
8.3.9. Anti-histamines/ Anti-allergy
8.3.10. Others
8.4. Market Attractiveness Analysis By Product
9. Global Small MoleculeSmall-Molecule Injectable Market Analysis 2016-2020 and Forecast 2021-2031, by Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2016–2020
9.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Application, 2021-2031
9.3.1. Oncology
9.3.2. Pain Management
9.3.3. Cardiovascular Diseases
9.3.4. Infectious Diseases
9.3.5. CNS Diseases
9.3.6. Blood Disorders
9.3.7. Musculoskeletal Disorders
9.3.8. Others
9.4. Market Attractiveness Analysis By Application
10. Global Small MoleculeSmall-Molecule Injectable Market Analysis 2016-2020 and Forecast 2021-2031, by Route of Administration
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016–2020
10.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Route of Administration, 2021-2031
10.3.1. Intravenous
10.3.2. Intramuscular
10.3.3. Subcutaneous
10.4. Market Attractiveness Analysis By Route of Administration
11. Global Small MoleculeSmall-Molecule Injectable Market Analysis 2016-2020 and Forecast 2021-2031, by Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016–2020
11.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Distribution Channel, 2021-2031
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Drug Stores
11.3.4. Mail Order Pharmacies
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Small MoleculeSmall-Molecule Injectable Market Analysis 2016-2020 and Forecast 2021-2031, by Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2020
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis By Region
13. North America Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
13.3. Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1.1. U.S.
13.3.1.1.2. Canada
13.3.2. By Product
13.3.3. By Application
13.3.4. By Route of Administration
13.3.5. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints - Impact Analysis
13.6. Key Market Participants - Intensity Mapping
14. Latin America Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
14.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Application
14.3.4. By Route of Administration
14.3.5. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints - Impact Analysis
14.6. Key Market Participants - Intensity Mapping
15. Europe Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
15.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Application
15.3.4. By Route of Administration
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. South Asia Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
16.3. Current and Future Market Size (US$ Mn) and Volume (Absolute) Trend Analysis and Forecast By Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Application
16.3.4. By Route of Administration
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints - Impact Analysis
16.6. Key Market Participants - Intensity Mapping
17. East Asia Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
17.3. Current and Future Market Size (US$ Mn) and Volume (Absolute) Trend Analysis and Forecast By Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Application
17.3.4. By Route of Administration
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints - Impact Analysis
17.6. Key Market Participants - Intensity Mapping
18. Oceania Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
18.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Application
18.3.4. By Route of Administration
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints - Impact Analysis
18.6. Key Market Participants - Intensity Mapping
19. Middle East and Africa Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
19.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. Northern Africa
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Application
19.3.4. By Route of Administration
19.3.5. By Distribution Channel
19.4. Market Attractiveness Analysis
19.5. Drivers and Restraints - Impact Analysis
19.6. Key Market Participants - Intensity Mapping
20. Key and Emerging Countries Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. U.S. Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.2.1. By Product
20.2.2. By Application
20.2.3. By Route of Administration
20.2.4. By Distribution Channel
20.3. Canada Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.3.1. By Product
20.3.2. By Application
20.3.3. By Route of Administration
20.3.4. By Distribution Channel
20.4. Mexico Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.4.1. By Product
20.4.2. By Application
20.4.3. By Route of Administration
20.4.4. By Distribution Channel
20.5. Brazil Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.5.1. By Product
20.5.2. By Application
20.5.3. By Route of Administration
20.5.4. By Distribution Channel
20.6. Argentina Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.6.1. By Product
20.6.2. By Application
20.6.3. By Route of Administration
20.6.4. By Distribution Channel
20.7. U.K. Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.7.1. By Product
20.7.2. By Application
20.7.3. By Route of Administration
20.7.4. By Distribution Channel
20.8. Germany Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.8.1. By Product
20.8.2. By Application
20.8.3. By Route of Administration
20.8.4. By Distribution Channel
20.9. France Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.9.1. By Product
20.9.2. By Application
20.9.3. By Route of Administration
20.9.4. By Distribution Channel
20.10. Italy Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.10.1. By Product
20.10.2. By Application
20.10.3. By Route of Administration
20.10.4. By Distribution Channel
20.11. Spain Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.11.1. By Product
20.11.2. By Application
20.11.3. By Route of Administration
20.11.4. By Distribution Channel
20.12. BENELUX Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.12.1. By Product
20.12.2. By Application
20.12.3. By Route of Administration
20.12.4. By Distribution Channel
20.13. Russia Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.13.1. By Product
20.13.2. By Application
20.13.3. By Route of Administration
20.13.4. By Distribution Channel
20.14. China Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.14.1. By Product
20.14.2. By Application
20.14.3. By Route of Administration
20.14.4. By Distribution Channel
20.15. Japan Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.15.1. By Product
20.15.2. By Application
20.15.3. By Route of Administration
20.15.4. By Distribution Channel
20.16. South Korea Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.16.1. By Product
20.16.2. By Application
20.16.3. By Route of Administration
20.16.4. By Distribution Channel
20.17. India Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.17.1. By Product
20.17.2. By Application
20.17.3. By Route of Administration
20.17.4. By Distribution Channel
20.18. ASEAN Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.18.1. By Product
20.18.2. By Application
20.18.3. By Route of Administration
20.18.4. By Distribution Channel
20.19. Australia Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.19.1. By Product
20.19.2. By Application
20.19.3. By Route of Administration
20.19.4. By Distribution Channel
20.20. New Zealand Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.20.1. By Product
20.20.2. By Application
20.20.3. By Route of Administration
20.20.4. By Distribution Channel
20.21. GCC Countries Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.21.1. By Product
20.21.2. By Application
20.21.3. By Route of Administration
20.21.4. By Distribution Channel
20.22. Turkey Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.22.1. By Product
20.22.2. By Application
20.22.3. By Route of Administration
20.22.4. By Distribution Channel
20.23. South Africa Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031
20.23.1. By Product
20.23.2. By Application
20.23.3. By Route of Administration
20.23.4. By Distribution Channel
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Concentration
21.4. Market Presence Analysis
21.4.1. By Regional footprint of Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Aurobindo Pharma Limited
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Profitability by Market Segments (Product/Channel/Region)
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.1.5.1. Marketing Strategy
22.3.1.5.2. Product Strategy
22.3.1.5.3. Channel Strategy
22.3.2. Teva Pharmaceutical Industries Ltd.
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Profitability by Market Segments (Product/Channel/Region)
22.3.2.4. Sales Footprint
22.3.2.5. Strategy Overview
22.3.2.5.1. Marketing Strategy
22.3.2.5.2. Product Strategy
22.3.2.5.3. Channel Strategy
22.3.3. Merck & Co. Inc.
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Profitability by Market Segments (Product/Channel/Region)
22.3.3.4. Sales Footprint
22.3.3.5. Strategy Overview
22.3.3.5.1. Marketing Strategy
22.3.3.5.2. Product Strategy
22.3.3.5.3. Channel Strategy
22.3.4. AstraZeneca Plc
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Profitability by Market Segments (Product/Channel/Region)
22.3.4.4. Sales Footprint
22.3.4.5. Strategy Overview
22.3.4.5.1. Marketing Strategy
22.3.4.5.2. Product Strategy
22.3.4.5.3. Channel Strategy
22.3.5. Pfizer Inc
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Profitability by Market Segments (Product/Channel/Region)
22.3.5.4. Sales Footprint
22.3.5.5. Strategy Overview
22.3.5.5.1. Marketing Strategy
22.3.5.5.2. Product Strategy
22.3.5.5.3. Channel Strategy
22.3.6. Sun Pharmaceutical Industries Ltd.
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Profitability by Market Segments (Product/Channel/Region)
22.3.6.4. Sales Footprint
22.3.6.5. Strategy Overview
22.3.6.5.1. Marketing Strategy
22.3.6.5.2. Product Strategy
22.3.6.5.3. Channel Strategy
22.3.7. Novartis AG
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Profitability by Market Segments (Product/Channel/Region)
22.3.7.4. Sales Footprint
22.3.7.5. Strategy Overview
22.3.7.5.1. Marketing Strategy
22.3.7.5.2. Product Strategy
22.3.7.5.3. Channel Strategy
22.3.8. Baxter International
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Profitability by Market Segments (Product/Channel/Region)
22.3.8.4. Sales Footprint
22.3.8.5. Strategy Overview
22.3.8.5.1. Marketing Strategy
22.3.8.5.2. Product Strategy
22.3.8.5.3. Channel Strategy
22.3.9. Fresenius Kabi
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Profitability by Market Segments (Product/Channel/Region)
22.3.9.4. Sales Footprint
22.3.9.5. Strategy Overview
22.3.9.5.1. Marketing Strategy
22.3.9.5.2. Product Strategy
22.3.9.5.3. Channel Strategy
22.3.10. Cipla Ltd
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Profitability by Market Segments (Product/Channel/Region)
22.3.10.4. Sales Footprint
22.3.10.5. Strategy Overview
22.3.10.5.1. Marketing Strategy
22.3.10.5.2. Product Strategy
22.3.10.5.3. Channel Strategy
22.3.11. Mylan N.V.
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Profitability by Market Segments (Product/Channel/Region)
22.3.11.4. Sales Footprint
22.3.11.5. Strategy Overview
22.3.11.5.1. Marketing Strategy
22.3.11.5.2. Product Strategy
22.3.11.5.3. Channel Strategy
22.3.12. Sanofi S.A
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Profitability by Market Segments (Product/Channel/Region)
22.3.12.4. Sales Footprint
22.3.12.5. Strategy Overview
22.3.12.5.1. Marketing Strategy
22.3.12.5.2. Product Strategy
22.3.12.5.3. Channel Strategy
22.3.13. Dr. Reddy’s Laboratories Ltd
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Profitability by Market Segments (Product/Channel/Region)
22.3.13.4. Sales Footprint
22.3.13.5. Strategy Overview
22.3.13.5.1. Marketing Strategy
22.3.13.5.2. Product Strategy
22.3.13.5.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Expenditure on Health (% of GDP) by Country, 2016-2021
Table 02: Expenditure on Health (% of GDP) by Country, 2016-2021
Table 03: Global Small MoleculeSmall-Molecule Injectable Market Size Value (US$ Bn) Analysis 2016–2020 and Forecast 2021–2031 , By Product
Table 04: Global Small MoleculeSmall-Molecule Injectable Market Size Value (US$ Bn) Analysis 2016–2020 and Forecast 2021–2031 , By Application
Table 05: Global Small MoleculeSmall-Molecule Injectable Market Size Value (US$ Bn) Analysis 2016–2020 and Forecast 2021–2031 , By Route of Administration
Table 06: Global Small MoleculeSmall-Molecule Injectable Market Size Value (US$ Bn) Analysis 2016–2020 and Forecast 2021–2031 , By Distribution Channel
Table 07: Global Small MoleculeSmall-Molecule Injectable Market Size Value (US$ Bn) Analysis 2016–2020 and Forecast 2021–2031, By Region
Table 08: North America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country
Table 09: North America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product
Table 10: North America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application
Table 11: North America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration
Table 12: North America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel
Table 13: Latin America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country
Table 14: Latin America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product
Table 15: Latin America Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application
Table 16: Latin America Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration
Table 17: Latin America Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel
Table 18: Europe Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country
Table 19: Europe Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product
Table 20: Europe Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application
Table 21: Europe Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration
Table 22 Europe Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel
Table 23: South Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country
Table 24: South Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product
Table 25: South Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application
Table 26: South Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration
Table 27: South Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel
Table 28: East Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country
Table 29: East Asia Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product
Table 30: East Asia Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application
Table 31: East Asia Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration
Table 32: East Asia Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel
Table 33: Oceania Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country
Table 34: Oceania Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product
Table 35: Oceania Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application
Table 36: Oceania Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration
Table 37: Oceania Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel
Table 38: MEA Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country
Table 39: MEA Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product
Table 40: MEA Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application
Table 41: MEA Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration
Table 42: MEA Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Small MoleculeSmall-Molecule Injectable Market Value Share, By Product (2021)
Figure 02: Global Small MoleculeSmall-Molecule Injectable Market Value Share, By Application (2021)
Figure 03: Global Small MoleculeSmall-Molecule Injectable Market Value Share, By Route of Administration (2021)
Figure 04: Global Small MoleculeSmall-Molecule Injectable Market Value Share, By Distribution Channel (2021)
Figure 05: Global Small MoleculeSmall-Molecule Injectable Market Value Share, By Region (2021)
Figure 07: Pipeline Products Share (%), by Phase (2020)
Figure 06: Pipeline Products Share (%), by Therapeutic Area (2020)
Figure 08: Global Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2016-2020
Figure 09: Global Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021–2031
Figure 10: Global Small MoleculeSmall-Molecule Injectable Market Absolute $ Opportunity, 2021-2031
Figure 11: Global Small MoleculeSmall-Molecule Injectable Market Analysis by Product –2021 & 2031
Figure 12: Global Small MoleculeSmall-Molecule Injectable Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 13: Global Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021–2031
Figure 14: Global Small MoleculeSmall-Molecule Injectable Market Share Analysis (%) By Application, 2021 & 2031
Figure 15: Global Small MoleculeSmall-Molecule Injectable Market Y-o-Y Growth (%) By Application, 2021–2031
Figure 16: Global Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021–2031
Figure 17: Global Small MoleculeSmall-Molecule Injectable Market Share Analysis (%) By Route of Administration, 2021 & 2031
Figure 18: Global Small MoleculeSmall-Molecule Injectable Market Y-o-Y Growth (%) By Route of Administration, 2021–2031
Figure 19: Global Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021–2031
Figure 20: Global Small MoleculeSmall-Molecule Injectable Market Share Analysis (%) By Distribution Channel, 2021 & 2031
Figure 21: Global Small MoleculeSmall-Molecule Injectable Market Y-o-Y Growth (%) By Distribution Channel, 2021–2031
Figure 22: Global Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021–2031
Figure 23: Global Small MoleculeSmall-Molecule Injectable Market Share Analysis (%) By Region, 2021 & 2031
Figure 24: Global Small MoleculeSmall-Molecule Injectable Market Y-o-Y Growth (%) By Region, 2021–2031
Figure 25: Global Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Region, 2021–2031
Figure 26: North America Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020
Figure 27: North America Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031
Figure 29: North America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031
Figure 31: North America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031
Figure 28: North America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031
Figure 30: North America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031
Figure 32: North America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031
Figure 33: Latin America Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020
Figure 34: Latin America Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031
Figure 35: Latin America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031
Figure 36: Latin America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031
Figure 37: Latin America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031
Figure 38: Latin America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031
Figure 39: Latin America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031
Figure 40: Europe Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020
Figure 41: Europe Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031
Figure 42: Europe Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031
Figure 43: Europe Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031
Figure 44: Europe Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031
Figure 45: Europe Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031
Figure 46: Europe Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031
Figure 47: South Asia Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020
Figure 48: South Asia Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031
Figure 49: South Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031
Figure 50: South Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031
Figure 51: South Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031
Figure 52: South Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031
Figure 53: South Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031
Figure 54: East Asia Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020
Figure 55: East Asia Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031
Figure 56: East Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031
Figure 57: East Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031
Figure 58: East Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031
Figure 59: East Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031
Figure 60: East Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031
Figure 61: Oceania Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020
Figure 62: Oceania Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031
Figure 63: Oceania Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031
Figure 64: Oceania Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031
Figure 65: Oceania Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031
Figure 66: Oceania Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031
Figure 67: Oceania Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031
Figure 68: MEA Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020
Figure 69: MEA Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031
Figure 70: MEA Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031
Figure 71: MEA Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031
Figure 72: MEA Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031
Figure 73: MEA Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031
Figure 74: MEA Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031
Figure 75: U.S. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 76: U.S. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 77: U.S. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 78: U.S. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 79: U.S. Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 80: Canada Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 81: Canada Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 82: Canada Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 83: Canada Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 84: Canada Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 85: Brazil Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 86: Brazil Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 87: Brazil Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 88: Brazil Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 89: Brazil Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 90: Mexico Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 91: Mexico Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 92: Mexico Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 93: Mexico Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 94: Mexico Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 95: Argentina Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 96: Argentina Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 97: Argentina Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 98: Argentina Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 99: Argentina Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 100: Germany Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 101: Germany Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 102: Germany Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 103: Germany Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 104: Germany Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 105: Italy Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 106: Italy Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 107: Italy Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 108: Italy Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 109: Italy Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 110: France Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 111: France Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 112: France Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 113: France Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 114: France Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 115: U.K. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 116: U.K. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 117: U.K. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 118: U.K. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 119: U.K. Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 120: Spain Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 121: Spain Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 122: Spain Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 123: Spain Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 124: Spain Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 125: Benelux Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 126: Benelux Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 127: Benelux Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 128: Benelux Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 129: Benelux Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 130: Russia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 131: Russia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 132: Russia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 133: Russia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 134: Russia Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 135: China Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 136: China Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 137: China Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 138: China Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 139: China Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 140: Japan Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 141: Japan Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 142: Japan Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 143: Japan Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 144: Japan Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 145: South Korea Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 146: South Korea Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 147: South Korea Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 148: South Korea Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 149: South Korea Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 150: India Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 151: India Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 152: India Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 153: India Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 154: India Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 155: Thailand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 156: Thailand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 157: Thailand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 158: Thailand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 159: Thailand Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 160: Malaysia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 161: Malaysia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 162: Malaysia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 163: Malaysia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 164: Malaysia Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 165: Australia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 166: Australia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 167: Australia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 168: Australia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 169: Australia Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 170: New Zealand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 171: New Zealand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 172: New Zealand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 173: New Zealand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 174: New Zealand Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 175: GCC Countries Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 176: GCC Countries Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 177: GCC Countries Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 178: GCC Countries Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 179: GCC Countries Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Figure 180: South Africa Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031
Figure 181: South Africa Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031
Figure 182: South Africa Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031
Figure 183: South Africa Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031
Figure 184: South Africa Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
